BACE : Lead Target for Orchestrated Therapy of Alzheimer's Disease /
BACE inhibitors and their use in the treatment of Alzheimer's Disease. BACE (ß-site of APP cleaving enzyme) is a critical component in Alzheimer's Disease (AD), and the development of BACE inhibitors shows great potential as a therapy for the disease. BACE: Lead Target for Orchestrated The...
Saved in:
Other Authors: | |
---|---|
Format: | Electronic eBook |
Language: | English |
Published: |
Hoboken, N.J. :
John Wiley & Sons,
©2010.
|
Subjects: | |
Online Access: |
Full text (Emmanuel users only) |
MARC
LEADER | 00000cam a2200000 a 4500 | ||
---|---|---|---|
001 | in00000240322 | ||
006 | m o d | ||
007 | cr cn||||||||| | ||
008 | 100507s2010 njuaf ob 001 0 eng d | ||
005 | 20240703150121.4 | ||
010 | |z 2009037093 | ||
019 | |a 609858657 |a 613206420 |a 647893954 |a 746577406 |a 816367561 |a 961556966 |a 962614376 |a 974508799 |a 974572917 |a 1018085985 |a 1043500706 |a 1047742897 |a 1053306145 |a 1053507333 |a 1058609038 |a 1100833884 |a 1257349480 | ||
020 | |a 9780470594087 | ||
020 | |a 047059408X | ||
020 | |a 9780470594070 |q (electronic bk.) | ||
020 | |a 0470594071 |q (electronic bk.) | ||
020 | |a 128249175X | ||
020 | |a 9781282491755 | ||
020 | |a 047029342X |q (cloth) | ||
020 | |a 9780470293423 |q (cloth) | ||
020 | |z 9780470293423 |q (cloth) | ||
020 | |a 9786612491757 | ||
020 | |a 6612491752 | ||
024 | 7 | |a 10.1002/9780470594087 |2 doi | |
035 | |a (OCoLC)612346151 |z (OCoLC)609858657 |z (OCoLC)613206420 |z (OCoLC)647893954 |z (OCoLC)746577406 |z (OCoLC)816367561 |z (OCoLC)961556966 |z (OCoLC)962614376 |z (OCoLC)974508799 |z (OCoLC)974572917 |z (OCoLC)1018085985 |z (OCoLC)1043500706 |z (OCoLC)1047742897 |z (OCoLC)1053306145 |z (OCoLC)1053507333 |z (OCoLC)1058609038 |z (OCoLC)1100833884 |z (OCoLC)1257349480 | ||
037 | |a 10.1002/9780470594087 |b Wiley InterScience |n http://www3.interscience.wiley.com | ||
040 | |a DG1 |b eng |e pn |c DG1 |d N$T |d YDXCP |d IDEBK |d E7B |d DG1 |d OCLCQ |d OCLCA |d OCLCQ |d NLGGC |d EBLCP |d UKDOC |d OCLCQ |d COO |d OCLCQ |d NKT |d OCLCQ |d AZK |d DG1 |d YDX |d DG1 |d COCUF |d CHVBK |d MOR |d LIP |d PIFAG |d ZCU |d OCLCQ |d MERUC |d OCLCQ |d U3W |d OCLCQ |d OCLCF |d OCLCO |d STF |d WRM |d NRAMU |d RRP |d ICG |d INT |d VT2 |d OCLCO |d AU@ |d OCLCO |d OCLCQ |d WYU |d OCLCO |d OCLCA |d TKN |d OCLCO |d OCLCA |d OCLCQ |d OCLCO |d DKC |d OCLCQ |d OCLCA |d CEF |d UX1 |d HS0 |d OCLCA |d REDDC |d OCLCO |d OCLCQ |d OCLCO |d INARC |d OCLCL |d OCLCQ |d SXB | ||
050 | 4 | |a RC523 |b .B24 2010 | |
060 | 4 | |a 2010 D-427 | |
060 | 4 | |a WT 155 |b B117 2010 | |
072 | 7 | |a MED |x 032000 |2 bisacsh | |
072 | 7 | |a MED |x 058060 |2 bisacsh | |
072 | 7 | |a MJ |2 bicssc | |
082 | 0 | 4 | |a 618.97/6831 |2 22 |
245 | 0 | 0 | |a BACE : |b Lead Target for Orchestrated Therapy of Alzheimer's Disease / |c edited by Varghese John. |
246 | 3 | 0 | |a Beta-site APP Cleaving Enzyme |
260 | |a Hoboken, N.J. : |b John Wiley & Sons, |c ©2010. | ||
300 | |a 1 online resource (1 electronic resource (xvi, 250 pages, 16 unnumbered pages of plates)) : |b illustrations (some color) | ||
336 | |a text |b txt |2 rdacontent | ||
337 | |a computer |b c |2 rdamedia | ||
338 | |a online resource |b cr |2 rdacarrier | ||
347 | |a data file |2 rda | ||
380 | |a Bibliography | ||
504 | |a Includes bibliographical references and index. | ||
505 | 0 | |a BACE : APP processing, and signal transduction in Alzheimer's disease / Dale E. Bredesen and Edward H. Koo -- Identification of BACE as a target in Alzheimer's disease / Robert L. Heinrikson and Sukanto Sinha -- BACE biological assays / Alfredo G. Tomasselli and Michael J. Bienkowski -- Peptidic, peptidomimetic, and HTS based BACE inhibitors / James P. Beck and Dustin J. Mergott -- Fragment-based approaches for identification of BACE inhibitors / Andreas Kuglstatter and Michael Hennig -- Structure-based drug design of BACE inhibitors : technical and practical aspects of preparation, 3-dimensional structure, and computational analysis / Felix F. Vajdos, Veerabahu Shanmugasundaram, and Alfredo G. Tomasselli -- Pharmacological models for preclinical testing : from mouse to dog to non-human primates / Jason L. Eriksen, Michael Paul Murphy, and Elizabeth Head -- Adsorption, distribution, metabolism, excretion (ADME), efficacy, and toxicology for BACE inhibitors / Ishrut Hussain and Emmanuel Demont -- Clinical trials for disease-modifying drugs such as BACE inhibitors / Henry H. Hsu -- Future strategies for development of novel BACE inhibitors : anti-APP B-site antibody and APP binding small molecule approaches for Alzheimer's disease / Beka Solomon [and others]. | |
506 | |a Access restricted to Ryerson students, faculty and staff. |5 CaOTR | ||
520 | |a BACE inhibitors and their use in the treatment of Alzheimer's Disease. BACE (ß-site of APP cleaving enzyme) is a critical component in Alzheimer's Disease (AD), and the development of BACE inhibitors shows great potential as a therapy for the disease. BACE: Lead Target for Orchestrated Therapy of Alzheimer's Disease covers virtually all aspects of BACE from initial identification, discovery of inhibitors, and challenges in clinical development, while providing a global understanding essential for productive and successful drug discovery. This book details the story of the discovery of BACE and. | ||
546 | |a English. | ||
588 | 0 | |a Print version record. | |
650 | 0 | |a Alzheimer's disease |x Chemotherapy. | |
650 | 0 | |a Aspartic proteinases |x Inhibitors |x Therapeutic use. | |
650 | 0 | |a Amyloid beta-protein precursor. | |
650 | 1 | 2 | |a Alzheimer Disease |x drug therapy |
650 | 2 | 2 | |a Amyloid Precursor Protein Secretases |x pharmacology |
650 | 2 | 2 | |a Amyloid Precursor Protein Secretases |x therapeutic use |
650 | 2 | |a Amyloid beta-Protein Precursor | |
700 | 1 | |a John, Varghese, |d 1958- |1 https://id.oclc.org/worldcat/entity/E39PCjCWckmyTW4VbT7C9hD8YP | |
758 | |i has work: |a BACE (Text) |1 https://id.oclc.org/worldcat/entity/E39PCFJG6qGPKVDw97f4VHCJ6q |4 https://id.oclc.org/worldcat/ontology/hasWork | ||
776 | 0 | 8 | |i Print version: |t BACE. |d Hoboken, N.J. : John Wiley & Sons, ©2010 |z 9780470293423 |z 047029342X |w (DLC) 2009037093 |w (OCoLC)436968376 |
852 | |b Online |h ProQuest | ||
856 | 4 | 0 | |u https://ebookcentral.proquest.com/lib/emmanuel/detail.action?docID=496021 |z Full text (Emmanuel users only) |t 0 |
938 | |a Internet Archive |b INAR |n isbn_9780470293423 | ||
938 | |a 123Library |b 123L |n 4539 | ||
938 | |a EBL - Ebook Library |b EBLB |n EBL496021 | ||
938 | |a ebrary |b EBRY |n ebr10373024 | ||
938 | |a EBSCOhost |b EBSC |n 317000 | ||
938 | |a ProQuest MyiLibrary Digital eBook Collection |b IDEB |n 249175 | ||
938 | |a YBP Library Services |b YANK |n 3133986 | ||
938 | |a YBP Library Services |b YANK |n 3201256 | ||
947 | |a FLO |x pq-ebc-base | ||
999 | f | f | |s 9df4736c-a3c5-4b05-8e07-cba94f05f792 |i b35100ed-da11-4ddd-a81b-5e8746eeb9f4 |t 0 |
952 | f | f | |a Emmanuel College |b Main Campus |c Emmanuel College Library |d Online |t 0 |e ProQuest |h Other scheme |
856 | 4 | 0 | |t 0 |u https://ebookcentral.proquest.com/lib/emmanuel/detail.action?docID=496021 |y Full text (Emmanuel users only) |